EC has snapped back sharply from its pre-earnings lows. The Colombian state oil producer gained 5.6% on Tuesday alone and is up 6.3% on the week, clawing back the losses that weighed on its May 13 earnings preview. That reversal — coming immediately after a Q1 results release that produced only a modest 0.8% next-day move — marks a notable shift in tone.
The Q1 print itself was benign rather than catalytic. The one-day reaction came in at just +0.8%, a fraction of the -5.5% decline that followed the prior quarter's results. That prior reading now looks like the outlier — the stock has clearly found buyers willing to re-engage at these levels. The next earnings date is August 11, giving the market roughly twelve weeks to digest the current setup.
The valuation story is straightforward and genuinely cheap. The P/E has eased modestly to 8.7x — down about 0.6 points over the past month — and EV/EBITDA has compressed to 4.4x, also down 0.3x over the same period. Revenue estimates imply roughly $32.5 billion in annual sales against a market cap in the $26–27 billion range. Net debt is substantial at around $25.5 billion, but operating cash flow of nearly $9.9 billion gives the company a clear path to service it. On a pure earnings-yield basis, the stock is generating over 11 cents per dollar invested — well above most comparably sized integrated oil peers. The EPS surprise rank at the 73rd percentile of the ORTEX universe confirms the company has a track record of coming in ahead of expectations.
The Wall Street consensus carries a note of caution. Analyst return potential is running at -10.9%, meaning the Street's consensus target is actually below the current price — an unusual alignment for a stock that just had a solid week. That discount to consensus target hints at either stale targets not yet revised up after the recent rally, or genuine disagreement about the forward oil price embedded in the model. The 12-month forward yield of 5.85% provides a floor of sorts. Dividend history in the data is stale, going back only to 2022 extraordinary payments, so the yield figure should be treated as an estimate rather than a confirmed commitment — particularly given the political backdrop around dividend policy flagged in earlier notes.
The institutional ownership picture is dominated by the Colombian government, which holds 88.5% of shares. That concentration is both a stability anchor and a risk factor: government decisions on dividends, capex, and contract policy directly set the tone for the minority float. Among international holders, BlackRock added 4.3 million shares through April, and several quantitative managers — including Two Sigma, D.E. Shaw, and Connor Clark & Lunn — have been building meaningful positions. Marshall Wace added over 8.3 million shares through March, a sizeable move for a hedge fund in a stock this thinly floated at the margin. That combination of quant money and systematic hedge funds piling in alongside a genuine value proposition helps explain the sharp weekly move.
Short positioning is not a primary driver here. The ORTEX short score sits at 47.4 — mid-range and non-directional. Days to cover at 6.98 suggest some short presence, but nothing extreme. Borrow availability data is stale and borrow costs remain low, consistent with the picture from the May 13 note: this is not a squeeze story, it is a re-rating one. OXY and CVX, two of Ecopetrol's closest US-listed peers by correlation, posted gains of 1.8% and 3.2% respectively on Tuesday. OXY is up 10.1% on the week — one of the strongest correlated movers — suggesting the broader energy tape has provided a meaningful tailwind for the Colombian name's bounce.
What to watch next: the August 11 earnings call will be the key reset point, and whether the current analyst consensus targets get revised to reflect the post-Q1 re-rating will determine whether the -10.9% gap to Street consensus narrows or stays inverted.
See the live data behind this article on ORTEX.
Open ECOPETROL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
